The fight against ivermectin appears to be never-ending. The newest attempt to discredit the antiviral medicine has been published in the New England Journal of Medicine. The study is rife with flaws. Ivermectin is doomed by the selection criterion. Because it is so readily disproved, its findings aren't even worth considering.
Debunking the latest flawed anti-ivermectin study
Debunking the latest flawed anti-ivermectin…
Debunking the latest flawed anti-ivermectin study
The fight against ivermectin appears to be never-ending. The newest attempt to discredit the antiviral medicine has been published in the New England Journal of Medicine. The study is rife with flaws. Ivermectin is doomed by the selection criterion. Because it is so readily disproved, its findings aren't even worth considering.